Form 4: Twist Bioscience Officer Sells Shares

Robert F. Werner, Chief Accounting Officer at Twist Bioscience Corp, reported a sale of 4,961 shares of common stock.

Summary

• Robert F. Werner, Chief Accounting Officer at Twist Bioscience Corp, sold 4,961 shares of common stock on May 8, 2026.
• The transaction was executed at a price of $56.881 per share.
• Following this transaction, Werner beneficially owns 49,674 shares of common stock.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as slightly negative due to an insider selling shares, which can be perceived as a lack of confidence, although the specific reasons for the sale are not disclosed.

Negatives

• A company executive sold a significant number of shares.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, which report insider transactions, are closely watched by investors for potential signals about a company's prospects. Executive stock sales can sometimes be interpreted negatively, though the reasons for such sales can vary.

Stakeholder Impact

• Shareholders may view the sale of shares by a company executive with caution, potentially impacting investor sentiment.

Key Dates

Recommendation

The filing reports an insider sale, which is a neutral to slightly negative event. Without further context on the reasons for the sale or broader company performance, a 'hold' recommendation is prudent for seasoned investors.

Keywords

Form 4, Insider Trading, Stock Sale, Twist Bioscience, Robert F. Werner, Chief Accounting Officer, Securities Exchange Act